Atorvastatin Calcium Patent Expiration
Atorvastatin Calcium is used for reducing LDL-C levels in patients with homozygous familial hypercholesterolemia. It was first introduced by Upjohn Manufacturing Ireland Unltd
Atorvastatin Calcium Patents
Given below is the list of patents protecting Atorvastatin Calcium, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Atorvaliq | US11369567 | Aqueous suspension suitable for oral administration | Jun 07, 2037 | Cmp Dev Llc |
Atorvaliq | US11654106 | Aqueous suspension suitable for oral administration | Jun 07, 2037 | Cmp Dev Llc |
Atorvaliq | US11925704 | Aqueous suspension suitable for oral administration | Jun 07, 2037 | Cmp Dev Llc |
Atorvaliq | US12168069 | Aqueous suspension suitable for oral administration | Jun 07, 2037 | Cmp Dev Llc |
Lipitor |
US5969156 (Pediatric) | Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
Jan 08, 2017
(Expired) | Upjohn |
Lipitor | US5969156 | Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
Jul 08, 2016
(Expired) | Upjohn |
Lipitor |
US5686104 (Pediatric) | Stable oral CI-981 formulation and process of preparing same |
May 11, 2015
(Expired) | Upjohn |
Lipitor | US5686104 | Stable oral CI-981 formulation and process of preparing same |
Nov 11, 2014
(Expired) | Upjohn |
Lipitor |
US6126971 (Pediatric) | Stable oral CI-981 formulation and process for preparing same |
Jul 19, 2013
(Expired) | Upjohn |
Lipitor | US6126971 | Stable oral CI-981 formulation and process for preparing same |
Jan 19, 2013
(Expired) | Upjohn |
Atorvastatin Calcium's Family Patents

Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List